Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone in persistent neonatal pulmonary hypertension
IRCT20220130053890N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of milrinone in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Iran University of Medical Sciences. Started Mar 2022; status: completed.
02
Drugs
milrinone
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on IRCT20220130053890N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220130053890N1.